Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Employee Benefits topic
No spam. Unsubscribe anytime.
EBD oversight subcommittee reviews March 2025 pharmacy and declines regional APTUS Financial contract without motion
Summary
The Employee Benefit Division oversight subcommittee reviewed March 2025 pharmacy and medical drug formulary recommendations; a proposed regional contract with APTUS Financial was considered but not approved because no motion was made.
The Employee Benefit Division (EBD) oversight subcommittee met on April 8, 2025, to review EBD’s March 2025 pharmacy formulary and medical drug formulary recommendations. Grant Wallace, identified in the meeting transcript as director of EBD, presented the recommendations and the subcommittee’s request for approval of a regional contract with APTUS Financial.
According to the transcript, the subcommittee “considered EBD's request for approval of a regional contract with…APTUS Financial,” but “with no motion, the contract was not approved.” The transcript attributes the presentation of the formulary recommendations and the contract request to Grant Wallace.
The record does not show a motion to approve the APTUS Financial contract, nor does it record a vote on the contract. The transcript also does not provide contract value, contract term, or details of the procurement process. The subcommittee later moved to adopt the subcommittee’s written report; that adoption motion carried by voice vote.
Because no approval motion was made for the APTUS Financial regional contract at this meeting, the contract was not advanced by the subcommittee during this session. No further assignment or direction to staff about the contract appears in the meeting transcript.
